Skip to main content
. 2015 Dec 20;18(12):734–739. [Article in Chinese] doi: 10.3779/j.issn.1009-3419.2015.12.04

2.

EGFR突变患者与野生型患者的疗效比较

The efficacy of icotinib in EGFR mutation and wild-type patients

Response Mutation Wild-type P
Complete response 0 (0) 0 (0) -
Partial response 63 (63.6)% 1 (4.0)% -
Stable response 30 (30.3)% 5 (24.0)% -
Progressive disease 6 (6.1)% 19 (72.0)% -
Response rate 63.6% 4.0% < 0.001
Disease control rate 93.9% 24.0% < 0.001
Median progression-free survival (month) 10.5 1.0 < 0.001